Literature DB >> 29225526

Scratching the Surface in Autoimmune Epilepsy: It is the Time to Dig Deeper, But How?

Adriana Bermeo-Ovalle.   

Abstract

Entities:  

Year:  2017        PMID： 29225526      PMCID： PMC5716115          DOI： 10.5698/1535-7597.17.4.225

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  11 in total

1.  Population-level evidence for an autoimmune etiology of epilepsy.

Authors:  Mei-Sing Ong; Isaac S Kohane; Tianxi Cai; Mark P Gorman; Kenneth D Mandl
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

2.  Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies.

Authors:  Mar Carreño; Christian G Bien; Ali A Asadi-Pooya; Michael Sperling; Petr Marusic; Martin Elisak; Jose Pimentel; Tim Wehner; Rajiv Mohanraj; Juan Uranga; Asier Gómez-Ibáñez; Vicente Villanueva; Francisco Gil; Antonio Donaire; Nuria Bargalló; Jordi Rumià; Pedro Roldán; Xavier Setoain; Luis Pintor; Teresa Boget; Eva Bailles; Mercè Falip; Javier Aparicio; Josep Dalmau; Francesc Graus
Journal:  Epilepsy Res       Date:  2016-12-15       Impact factor: 3.045

3.  Serum antibodies in epilepsy and seizure-associated disorders.

Authors:  K McKnight; Y Jiang; Y Hart; A Cavey; S Wroe; M Blank; Y Shoenfeld; A Vincent; J Palace; B Lang
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

Review 4.  Paraneoplastic epilepsy.

Authors:  Anna Serafini; Rimas V Lukas; Stephen VanHaerents; Peter Warnke; James X Tao; Sandra Rose; Shasha Wu
Journal:  Epilepsy Behav       Date:  2016-06-12       Impact factor: 2.937

5.  Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy.

Authors:  Divyanshu Dubey; Niyatee Samudra; Puneet Gupta; Mark Agostini; Kan Ding; Paul C Van Ness; Steven Vernino; Ryan Hays
Journal:  Seizure       Date:  2015-04-30       Impact factor: 3.184

6.  Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology.

Authors:  Divyanshu Dubey; Abdulradha Alqallaf; Ryan Hays; Matthew Freeman; Kevin Chen; Kan Ding; Mark Agostini; Steven Vernino
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

7.  Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.

Authors:  S H Gultekin; M R Rosenfeld; R Voltz; J Eichen; J B Posner; J Dalmau
Journal:  Brain       Date:  2000-07       Impact factor: 13.501

Review 8.  Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.

Authors:  Marianna Spatola; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2017-06       Impact factor: 5.710

9.  Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort.

Authors:  Woo-Jin Lee; Soon-Tae Lee; Jung-Ick Byun; Jun-Sang Sunwoo; Tae-Joon Kim; Jung-Ah Lim; Jangsup Moon; Han Sang Lee; Yong-Won Shin; Keon-Joo Lee; Soyun Kim; Keun-Hwa Jung; Ki-Young Jung; Kon Chu; Sang Kun Lee
Journal:  Neurology       Date:  2016-04-01       Impact factor: 9.910

10.  Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.

Authors:  M Toledano; J W Britton; A McKeon; C Shin; V A Lennon; A M L Quek; E So; G A Worrell; G D Cascino; C J Klein; T D Lagerlund; E C Wirrell; K C Nickels; S J Pittock
Journal:  Neurology       Date:  2014-04-04       Impact factor: 9.910
View more
  1 in total

1.  Recurrent seizures of autoimmune origin: emerging phenotypes.

Authors:  Mathilde Goudot; Solène Frismand; Lucie Hopes; Antoine Verger; Bastien Joubert; Jérôme Honnorat; Louise Tyvaert
Journal:  J Neurol       Date:  2021-02-27       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.